Investments in AI Imaging Start-ups Increased to USD 580 Million in 2018
|
By HospiMedica International staff writers Posted on 07 Mar 2019 |
|
Image: HeartFlow develops non-invasive AI analysis software for creating 3D models of coronary arteries from CT scans (Photo courtesy of HeartFlow).
Capital investments in start-up companies developing medical imaging artificial intelligence (AI) solutions more than doubled to USD 580 million in 2018 from USD 270 million in 2017. These are the latest findings of Signify Research (Cranfield, Beds, UK), a market intelligence and research firm.
Currently, there are over 120 start-ups and growth-phase companies developing machine learning solutions for medical imaging, and have accumulated more than USD 1.2 billion in investments since 2014. Among the 10 most-funded companies in 2018, five belonged to the US, four came from Asia and one was based in Europe. However, in 2018, 10 new AI companies entered the market, marking a significant decline from the peak of 26 companies in 2016.
Out of the total capital investments of USD 580 million in 2018, USD 240 million was accumulated by HeartFlow, a Silicon Valley start-up founded in 2007 that develops non-invasive AI analysis software for creating 3D models of coronary arteries from CT scans. Among the 84 companies that disclosed funding for the period 2014 to 2018, the average funding per company was USD 14.4 million (USD 9.2 million excluding HeartFlow).
“While the number of new market entrants peaked in 2016, 10 additional companies entered the market in 2018 and more are expected this year,” said Simon Harris, principal analyst at Signify Research. “This nascent market is becoming increasingly crowded and the need to differentiate is paramount. In 2018, investors started to focus more on mid-and later-stage deals, suggesting that the sector is maturing, although the number of early-stage deals was still higher.”
Related Links:
Signify Research
Currently, there are over 120 start-ups and growth-phase companies developing machine learning solutions for medical imaging, and have accumulated more than USD 1.2 billion in investments since 2014. Among the 10 most-funded companies in 2018, five belonged to the US, four came from Asia and one was based in Europe. However, in 2018, 10 new AI companies entered the market, marking a significant decline from the peak of 26 companies in 2016.
Out of the total capital investments of USD 580 million in 2018, USD 240 million was accumulated by HeartFlow, a Silicon Valley start-up founded in 2007 that develops non-invasive AI analysis software for creating 3D models of coronary arteries from CT scans. Among the 84 companies that disclosed funding for the period 2014 to 2018, the average funding per company was USD 14.4 million (USD 9.2 million excluding HeartFlow).
“While the number of new market entrants peaked in 2016, 10 additional companies entered the market in 2018 and more are expected this year,” said Simon Harris, principal analyst at Signify Research. “This nascent market is becoming increasingly crowded and the need to differentiate is paramount. In 2018, investors started to focus more on mid-and later-stage deals, suggesting that the sector is maturing, although the number of early-stage deals was still higher.”
Related Links:
Signify Research
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Wound Irrigation Solution
Prontosan®
New
Digital Radiography System (Ceiling Free)
Digix CF Series
Latest AI News
- Machine Learning Approach Enhances Liver Cancer Risk Stratification
- New AI Approach Monitors Brain Health Using Passive Wearable Data
- AI Tool Maps Early Risk Patterns in Bloodstream Infections
- AI Model Identifies Rare Endocrine Disorder from Hand Images
- AI Tool Promises to Reduce Length of Hospital Stays and Free Up Beds
- Machine Learning Model Cuts Canceled Liver Transplants By 60%
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
